ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

The effects of type 1 and type 2 diabetes on bone and fracture risk

The effects of type 1 and type 2 diabetes on bone and fracture risk
  Type 1 diabetes Type 2 diabetes
Physiologic profile
  • Insulin deficiency
  • Elevated blood glucose
  • Insulin resistance
  • Hyperinsulinemia
  • Elevated blood glucose
Usual age of diabetes onset
  • Younger
  • May affect peak bone mass
  • Older
  • Usually maturity onset
BMD
  • May be low
  • May be normal to increased
Fracture risk
  • Increased
  • Increased
BMI and influence on bone
  • Historically lower, but now resembles the distribution in the general population
  • Usually high
  • Increased load on skeleton
  • Increased soft tissue may protect against impact
  • Increased estrogen, leptin, and adiponectin production in adipose tissue; low testosterone levels in men
Other mechanism(s) of bone fragility
  • Hyperglycemia may cause increased urine calcium loss and inhibit bone formation
  • Abnormal bone microarchitecture (predominantly trabecular)
  • Bone turnover is usually low
  • Advanced glycation end products may embrittle bone material and adversely impact bone remodeling
  • Hyperglycemia may cause increased urine calcium loss and inhibit bone formation
  • Abnormal bone microarchitecture (predominantly cortical)
  • Bone turnover is usually low
  • Advanced glycation end products may embrittle bone material and adversely impact bone modeling
Diabetes pharmacotherapy
  • Insulin has anabolic effect
  • Adverse impact of thiazolidinediones and possibly SGLT2 inhibitors on bone strength
Other diabetes-related complications
  • Micro- and macrovascular complications may increase fracture risk by effects on bone (eg, by metabolic effects of nephropathy) or by association with an increased risk of falling (eg, secondary to visual loss, hypoglycemia, cerebrovascular disease, or neuropathy). Neuropathy-related local bone loss may increase fracture risk at the foot and ankle (Charcot foot).
IGF-1: insulin-like growth factor 1; BMD: bone mineral density; BMI: body mass index; SGLT2: sodium-glucose cotransporter 2.
Sources:
  1. Rakel A, Sheehy O, Rahme E, LeLorier J. Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab 2008; 34:193.
  2. Adami S. Bone health in diabetes: considerations for clinical management. Curr Med Res Opin 2009; 25:1057.
  3. Epstein S, Leroith D. Diabetes and fragility fractures - a burgeoning epidemic? Bone 2008; 43:3.
  4. McCulloch D. Thiazolidinediones in the treatment of diabetes mellitus. In: UpToDate, Basow DS (Ed), UpToDate, Waltham, MA, 2013.
Graphic 51539 Version 8.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟